- Home
- RVSB vs BOLD Comparison
RVSB vs BOLD Comparison
Compare RVSB & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- BOLD
- Stock Information
- Founded
- RVSB 1923
- BOLD 2018
- Country
- RVSB United States
- BOLD United States
- Employees
- RVSB N/A
- BOLD N/A
- Industry
- RVSB Savings Institutions
- BOLD
- Sector
- RVSB Finance
- BOLD
- Exchange
- RVSB Nasdaq
- BOLD Nasdaq
- Market Cap
- RVSB 99.6M
- BOLD 81.0M
- IPO Year
- RVSB 1993
- BOLD 2024
- Fundamental
- Price
- RVSB $4.74
- BOLD $2.95
- Analyst Decision
- RVSB
- BOLD Strong Buy
- Analyst Count
- RVSB 0
- BOLD 3
- Target Price
- RVSB N/A
- BOLD $23.00
- AVG Volume (30 Days)
- RVSB 17.9K
- BOLD 57.8K
- Earning Date
- RVSB 10-24-2024
- BOLD 11-11-2024
- Dividend Yield
- RVSB 1.70%
- BOLD N/A
- EPS Growth
- RVSB N/A
- BOLD N/A
- EPS
- RVSB 0.05
- BOLD N/A
- Revenue
- RVSB $46,297,000.00
- BOLD N/A
- Revenue This Year
- RVSB N/A
- BOLD N/A
- Revenue Next Year
- RVSB $12.93
- BOLD N/A
- P/E Ratio
- RVSB $98.52
- BOLD N/A
- Revenue Growth
- RVSB N/A
- BOLD N/A
- 52 Week Low
- RVSB $3.30
- BOLD $2.82
- 52 Week High
- RVSB $6.57
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- BOLD N/A
- Support Level
- RVSB $4.45
- BOLD N/A
- Resistance Level
- RVSB $4.72
- BOLD N/A
- Average True Range (ATR)
- RVSB 0.12
- BOLD 0.00
- MACD
- RVSB -0.00
- BOLD 0.00
- Stochastic Oscillator
- RVSB 61.43
- BOLD 0.00
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.